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Daily Serum Interleukin-6 Monitoring in Multiple Organ 
Transplantation With or Without Liver Allografts 
Y. Kita, Y. Iwaki, K. Noguchi, B.P. Griffith, A.G. Tzakis, S. Todo, J.J. Fung, and T.E. Starzl 
W E PREVIOUSLY reported that daily monitored 
serum or plasma interleukin-6 (lL-6) levels maybe a 
good premonitor of liver allograft rejection and also a 
useful predictor of long-term graft prognosis. I 
Histopathologically. liver allograft rejection is character-
ized by a cellular infiltration consisting mainly of mono-
cytes/macrophages and activated T lymphocytes. IL-6 is an 
inflammatory cytokine mainly secreted by monocytes/mac-
rophages and endothelial cells. Kupifer cells and vascular 
endothelial cells in the liver may also secrete IL-6. There-
fore, both infiltrating host immune cells and allograft cells 
(activated Kupifer and endothelial cells) may playa role in 
producing IL-6. The liver is the largest organ in the human 
body and potentially produces IL-6. The liver is also the 
major target organ of IL-6. 
To clarify this phenomenon (ie. that the major source of 
IL-6 is the liver allograft), we evaluated sequential serum 
IL-6 levels in various organ transplants with and without 
liver allografts. 
SUBJECTS AND METHODS 
FK 506 or cyclosporine (CyA). to which various doses of methyl-
prednisolone were added, were used for baseline suppression. 
OKT3 was given when indicated. Daily monitoring of serum IL-6 
was performed in cases of 18 kidney. 27 liver. 5 lung (single lung: 2. 
double lung: 3). 1 small bowel, 4 liver + kidney. 5 liver + islet 
(abdominal organ cluster transplantation), and 3 liver T small 
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Table 1. Number of Various Organ Transplants Undergoing 
Serum IL-6 Monitoring 
Transplants Cases 
Kidney 18 
Liver 27 
Lung 5' 
Small bowel 1 
Liver + kidney 4 
Liver + islets (cluster) 5 
liver + small bowel 3 
Total 63 
'Single: 2; double: 3. 
bowel transplantation using ELISA (Table I). ELISA was per-
formed using a TWo-step sandwich enzyme immunoassay method 
with Quantikine (Research and Diagnostic Systems Inc. Minneap-
olis. Minn.) as described elsewhere. I Daily monitored IL-6 levels 
were evaluated and compared to clinical courses and histopatho-
logical diagnosis of rejection in all cases. 
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Fig 1. A 52-year-old woman 
with alcoholic cirrhOSis under-
went liver transplantation. She 
had many relapsing rejection 
episodes. 
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Fig 2. Serum IL-6 monitoring in lung transplant recipients. 
Upper: Double-lung transplant recipient with no complications. 
Middle: Single-lung transplant recipient with one relection epI-
sode. Rejection was confirmed by bronchoalveolar lavage (BAL). 
An IL-6 spike was observed 1 day before BAL. Lower: Double-
lung transplant reCipient with bacterial infection In both lung 
allografts. IL-6 levels were consistently high. 
RESULTS 
The normal mean value of IL-6 from J() healthv volunteers 
was IX ::':: 3.+ pgtmL. of whom 21 (7Wr) had nondetecrable 
« 10 pgtml) levels. We defined the normal [L-Il cutotf 
levels as XIJ pg,'mL. which was the mcan ::: 2 SD va[ue of the 
30 healthy volunteers. 
The O1e;1O number of IL-6 measurements a\era!,!ed [6.5 
per patient. Ali patients with infection subsequentlv devel-
nped continuouslv high I L-h levels. Rejection cplsodes 
< lecurred in five cases (proven histopatholo!,!ically by ei!,!ht 
hiopsies) in kidncv transplantation. However. no splke-
\haped IL-Il elevations (>Xh pgtml) \\ere found in these 
cases. 
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In liver and liver + islet transplantation. serum or plasma 
levels of IL-6 were decreased after liver (or liver + islet) 
transplantation, regardless of pre transplant values. Patients 
with infection subsequently developed continuously high 
IL-6 levels. In patients without infection, significantly 
higher levels of IL-6 were usually found prior to the 
histopathological diagnosis of rejection. IL-6 elevation was 
spike-shaped, correlated poorly with the histological grade 
of rejection. and was highly responsive to augmented 
immunosuppression. One representative case with late-
phase relapsing rejection episodes is shown in Fig 1. On the 
same day or one day before the biopsy showing acute 
cellular rejection (ACR), an IL-6 spike was observed. 
Similar to the case with liver transplants, histopatholog-
ical rejection episodes involving lung allografts showed 
spike-shaped IL-6 elevations 0 to 2 days before histopatho-
logical diagnosis of rejection. Representative cases of no 
complication, rejection, and infection are shown in Fig 2. 
In the case of small bowel transplantation, no IL-6 
elevation was observed during mild ACR on postoperative 
day (POD) 6 and the prominent ACR on POD 14. Since 
prominent ACR was proved on POD 14. antirejection 
therapy was initiated soon and treated successfully (Fig 3). 
In contrast, in transplantations combined with liver allo-
grafts (liver + small bowel and liver + kidney), if the 
rejection episodes were found in the liver allograft, IL-6 
spikes were also found 0 to 4 days before histopathological 
rejection. Interestingly, even with rejection episodes in 
other allografts (small bowel or kidney), IL-6 spikes were 
also found in the same fashion. 
A 4-year-old boy with gastroschisis (Fig 4) underwent 
liver + small bowel transplantation. Neither the liver nor 
small bowel biopsy showed any histological rejection in this 
case. Although liver biopsy on POD 15 showed no signs of 
rejection. serum glutamate oxaloacetate transaminase 
(GOT) levels rose again on POD 111. indicating liver 
dysfunction possiblv due to rejection .. ·\n (L-6 elevation 
spike was observed on POD 13. 
A 26-year-old woman with superior mesenteric artery 
thrombosis (Fig':;) underwent liver i- small bowel trans-
plantation. Biopsies showed no signs of liver rejection. but 
clinical rejection was dia!,!nosed by the rise in serum total 
hilirubin (TI3) lC\ cis. Methylprednisolone bolus (I g) was 
administered ;111([ liver rejection appeared successfullv 
treated on POD 25. Biopsies undertaken on POD 25 and 
35. however. showed reJection or the small howel allograft. 
During this pertud (POD 25 to POD 35). IL-Il spikes were 
also observed. 
A D+~-year-uld man with primarv ,clerosing cholangitis 
and polycystic kidnev underwenl combined liver and kidnev 
transplantation. and the pu,ttransplant course was unevent-
ful (Fi!,! (J). Serum I L-h le\'els were alwavs in the normal 
range. 
:\ '+O-vear-old man with crvpto!,!enlc cirrhosis and chronic 
renal failure underwent combined I i\er and kidney trans-
plantation (Fi!! ., I. Biopsies ni hoth kidnev and liver allo-
grafts ,IHlwed Illl signs <)1 releellon: however. he sulfcred 
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Fig 3. A 31-year-old man with 
gunshot injury to the superior 
mesenteric artery underwent 
small bowel transplantation. 
The serum IL-6 level was high 
POD 1 to 2 but decreased after-
ward, and stayed within the nor-
mal range regardless of biopsy-
proven acute cellular rejection 
(ACR) episodes. 
from bacterial and fungal infection after POD 10. IL-6 
levels were very high after POD 10 except for a few days. 
In the case of a 29-year-old man with cryptogenic cirrho-
sis and chronic renal failure (Fig 8), the direct crossmatch 
test showed strong positive. Kidney biopsy on POD 18 
showed mild to moderate ACR and vascular rejection, and 
liver biopsy showed no ACR. IL-6 spikes were observed on 
the day of biopsy (POD 18) and POD 16. This patient 
suffered from overwhelming relapsing kidney rejection that 
necessitated nephrectomy after POD 50. The liver allograft 
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Fig 4. A 4-year-old boy With 
gastroschisis underwent com-
bined liver and small bowel 
transplant. One gram of methyl-
prednisolone was administered 
for clinically suspected liver allo-
graft relectlOn. 
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Fig 6. A 44-year-Old man with 
primary scleroSing cholangitis 
and polycystic kidney under-
went combined liver and kidney 
transplantation. The posttrans-
plant course was uneventful. 
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Fig 7. A 40-year-old man with 
cryptogenic cirrhosis and 
chronic renal failure underwent 
combined liver and kidney 
transplantation. He experienced 
bacterial and fungal infection af-
ter POD 10. 
Fig 8. A 29-year-old man With 
cryptogenic Cirrhosis and 
chroniC renal failure underwent 
combined kidney and liver 
transplantation. He experienced 
relapsing rejection of the kidney 
allograft and subsequently un-
derwent nephrectomy and liver 
retransplantatlon. 
1234 
was also damaged due to ischemic injury and possible 
rejection proven by open liver biopsy on POD 52. Until this 
procedure, many IL-6 spikes were observed. 
DISCUSSION 
In this study, we have shown that daily monitoring of serum 
IL-6 levels are useful in the diagnosis of graft rejection in 
recipients with liver allografts. Liver and possibly lung 
allografts may produce much more IL-6 than kidney al-
lografts during rejection episodes. 
Although Yoshimura et al2 reported the efficacy of IL-6 
in diagnosing renal allograft rejection, we could not detect 
high levels of serum IL-6 in kidney transplants, even in 
biopsy-proven rejection episodes found in five cases (eight 
biopsies). This is mainly attributable to the sensitivity of 
assay because Yoshimura et al used a bioassay method 
more sensitive than ours. 
Putting the EUSA assay sensitivity aside, in kidney or 
small bowel transplantation with liver allografts, we found 
significantly higher IL-6 concentrations in serum even when 
kidney or small bowel allografts were rejected. 
These results suggest that allografts of the liver and lung, 
which are relatively large organs compared to the kidney, 
may be major sources of IL-6 production during allograft 
rejection because the liver and lung contain many mono-
cytes/macrophages and large vascular endothelial beds, and 
also may have many infiltrating activated T cells at the time 
of rejection. 
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Hoffmann et all also suggested that the localization of 
tumor necrosis alpha (lNF-a)-producing cells correlated 
with the distribution of monocytes and macrophages in liver 
allografts and that concomitan~ plasma levels were elevated 
compared to those of controls without complications. Since 
it is well known that lNF-a induces IL-6 production, our 
findings also imply the intragraft production of inflamma-
tory cytokines during rejection episodes. 
Recently, Matsumoto et al4 reported that IL-6 partici-
pa~es in the regulation of human biliary epithelial cell 
growth in vitro. The ability of IL-6 to directly promote bile 
duct epithelium DNA synthesis provides a link between 
liver inflammation such as allograft rejection and the repair 
response. Thus, the control of inflammatory cytokines is 
important to obtain longer graft survival without biliary 
epithelial growth such as vanishing bile duct syndrome. 
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